Merrimack Pharmaceuticals (MACK) SEC Filings & 10K Form → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free mack Stock Alerts $15.00 -0.03 (-0.20%) (As of 05/3/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Recent Merrimack Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/30/20244:22 PMMerrimack Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/30/20244:24 PMMerrimack Pharmaceuticals (Filer)Form DEFA14A03/22/20248:46 AMMerrimack Pharmaceuticals (Filer)Form DEFA14A03/21/20243:48 PMMerrimack Pharmaceuticals (Filer)Form 10-K/A03/21/20243:52 PMMerrimack Pharmaceuticals (Filer)Form DEF 14A03/07/20243:39 PMMerrimack Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/07/20243:42 PMMerrimack Pharmaceuticals (Subject)Form 42503/07/202411:29 AMBlackRock Inc. (Filed by)Merrimack Pharmaceuticals (Subject)Form SC 13G/A02/22/20243:46 PMADAR1 Partners, LP (Filed by)Merrimack Pharmaceuticals (Subject)Form SCHEDULE 13G02/13/20243:22 PMMerrimack Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/31/20241:08 PMBlackRock Inc. (Filed by)Merrimack Pharmaceuticals (Subject)Form SC 13G12/28/20233:05 PMAndersen Eric (Reporting)Merrimack Pharmaceuticals (Issuer)Western Standard LLC (Reporting)WESTERN STANDARD PARTNERS LP (Reporting)Western Standard Partners QP, L.P. (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/20/20235:59 PMAndersen Eric (Reporting)Merrimack Pharmaceuticals (Issuer)Western Standard LLC (Reporting)WESTERN STANDARD PARTNERS LP (Reporting)Western Standard Partners QP, L.P. (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/16/20234:09 PMAndersen Eric (Reporting)Merrimack Pharmaceuticals (Issuer)Western Standard LLC (Reporting)WESTERN STANDARD PARTNERS LP (Reporting)Western Standard Partners QP, L.P. (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/02/20233:36 PMMerrimack Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/03/20233:36 PMMerrimack Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: Rigel Pharmaceuticals 10Q Form Verastem 10Q Form Vanda Pharmaceuticals 10Q Form Regulus Therapeutics 10Q Form XOMA 10Q Form Emergent BioSolutions 10Q Form Lexicon Pharmaceuticals 10Q Form OPKO Health 10Q Form Ovid Therapeutics 10Q Form Galectin Therapeutics 10Q Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:MACK) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merrimack Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.